Moderna
MRNA
1,141 hedge funds and large institutions have $93.5B invested in Moderna in 2021 Q3 according to their latest regulatory filings, with 322 funds opening new positions, 398 increasing their positions, 322 reducing their positions, and 74 closing their positions.
335% more first-time investments, than exits
New positions opened: 322 | Existing positions closed: 74
74% more capital invested
Capital invested by funds: $53.9B → $93.5B (+$39.7B)
26% more funds holding
Funds holding: 904 → 1,141 (+237)
24% more repeat investments, than reductions
Existing positions increased: 398 | Existing positions reduced: 322
22% more funds holding in top 10
Funds holding in top 10: 32 → 39 (+7)
3.22% more ownership
Funds ownership: 57.04% → 60.25% (+3.2%)
13% less call options, than puts
Call options by funds: $8.25B | Put options by funds: $9.5B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.76B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.58B |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.45B |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$887M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$557M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.35B |
| 2 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$1.11B |
| 3 |
TP
Theleme Partners
London,
United Kingdom
|
-$780M |
| 4 |
Morgan Stanley
New York
|
-$649M |
| 5 |
Renaissance Technologies
New York
|
-$438M |
MRNA Hedge Fund Activity: Q3 2021 in Review
1,141 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q3 2021, worth a combined $93.5B — up 74% from $53.9B a quarter earlier.
Buyers outnumbered sellers: 322 funds opened new MRNA positions and 74 closed out — a net gain of 248 holders — while 398 added to existing stakes and 322 trimmed.
The largest buyer was BlackRock, adding an estimated $2.76B. The largest seller was Baillie Gifford & Co, cutting an estimated $1.35B.
- 1,141 institutional investors held Moderna (MRNA) as of Q3 2021, up from 904 in Q2 2021.
- Funds reported $93.5B of Moderna stock for Q3 2021, up 74% quarter-over-quarter.
- 322 funds opened new Moderna positions in Q3 2021 and 74 closed out, a net change of +248 holders.
- The largest Moderna buyer in Q3 2021 was BlackRock, an estimated $2.76B added.
- The largest Moderna seller in Q3 2021 was Baillie Gifford & Co, an estimated $1.35B sold.
Based on aggregated 13F filings for Q3 2021.